Global Nuclear Medicine Market Size & Trends Report Segmented by Product (SPECT, PET, Alpha & Beta Emitters, Brachytherapy), Application (Cardiology, Neurology, Oncology, Urology, Thyroid, Lymphoma, Bone Metastasis), End-user (Hospitals, Diagnostic Centers) & Regional Forecasts to 2031

Global Nuclear Medicine Market Segmentation

This report by Medi-Tech Insights provides thesize of the global nuclear medicine market at theregional and country-level from 2024 to 2031. The report further segments the market by product, application, and end user.

Market Size & Forecast (2024-2031), By Product, USD Billion

• Diagnostics
  • SPECT
    • TC-99m
    • TL-201
    • GA-67
    • I-123
    • Others
  • PET
    • F-18
    • SR-82/RB-82
    • PYLARIFY (piflufolastat F 18)
    • Illuccix (gallium Ga 68 gozetotide)
    • Others
  • Therapeutics
    • Alpha Emitters
      • RA-223
      • Others
    • Beta Emitters
      • I-131
      • Y-90
      • SM-153
      • Re-186
      • Others
    • Brachytherapy
      • Cesium-131
      • Iodine-125
      • Palladium-103
      • Iridium-192
      • Others

Market Size & Forecast (2024-2031), By Application, USD Billion

• Cardiology
• Neurology
• Oncology
• Thyroid
• Lymphoma
• Bone Metastasis
• Endocrine Tumour
• Pulmonary Scans
• Urology
• Other Applications

Market Size & Forecast (2024-2031), By End User, USD Billion

• Hospitals
• Diagnostic Centers
• Other End Users

Market Size & Forecast (2024-2031), By Region, USD Billion

• North America
  • US
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Rest of Asia Pacific
• Latin America
• Middle East & Africa